AIM Toinvestigate the antivirus effects of Angelicapolysaccharidesulfate (APS) on L6565 murine leukemiavirus and discuss the possibilityof APS on AIDStherapy.
Currently my institution, which pioneered antiretroviral therapy in Africa and treats a large proportion of AIDS patients in Uganda, is not taking new patients due to lack of funding.